Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Mar 2, 2016
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (right To Purchase)
2016-03-01+25,000→ 25,000 totalExercise: $7.24Exp: 2026-03-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 25,000 shares of Common Stock, will become exercisable on February 16, 2017, with a 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.